These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37773558)

  • 1. Impact of dexmedetomidine on electrophysiological properties and arrhythmia inducibility in adult patients referred for reentrant supraventricular tachycardia ablation.
    Bernardini A; Paoletti Perini A; Padeletti M; Signorini U; Ciliberti D; Poli C; Milli M; Giomi A
    J Interv Card Electrophysiol; 2024 Mar; 67(2):371-378. PubMed ID: 37773558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiographic and electrophysiologic effects of dexmedetomidine on children.
    Ergul Y; Unsal S; Ozyilmaz I; Ozturk E; Carus H; Guzeltas A
    Pacing Clin Electrophysiol; 2015 Jun; 38(6):682-7. PubMed ID: 25753681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing the anesthetic and sedative drugs for supraventricular tachycardia ablations: A focused review.
    Vladinov G; Fermin L; Longini R; Ramos Y; Maratea E
    Pacing Clin Electrophysiol; 2018 Nov; 41(11):1555-1563. PubMed ID: 30251322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine Sedation for Paroxysmal Supraventricular Tachycardia Ablation Is Not Associated With Alteration of Arrhythmia Inducibility.
    Slupe AM; Minnier J; Raitt MH; Zarraga IGE; MacMurdy KS; Jessel PM
    Anesth Analg; 2019 Dec; 129(6):1529-1535. PubMed ID: 31743172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological features differentiating the atypical atrioventricular node-dependent long RP supraventricular tachycardias.
    Ho RT; Frisch DR; Pavri BB; Levi SA; Greenspon AJ
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):597-605. PubMed ID: 23629734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of dexmedetomidine on cardiac electrophysiology in children.
    Hammer GB; Drover DR; Cao H; Jackson E; Williams GD; Ramamoorthy C; Van Hare GF; Niksch A; Dubin AM
    Anesth Analg; 2008 Jan; 106(1):79-83, table of contents. PubMed ID: 18165557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine use in patients undergoing electrophysiological study for supraventricular tachyarrhythmias.
    Tirotta CF; Nguyen T; Fishberger S; Velis E; Olen M; Lam L; Madril DR; Hughes J; Lagueruela RG
    Paediatr Anaesth; 2017 Jan; 27(1):45-51. PubMed ID: 27779344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of human atrioventricular nodal function by selective atrioventricular nodal artery catheterization.
    Wang PJ; Sosa-Suarez G; Friedman PL
    Circulation; 1990 Sep; 82(3):817-29. PubMed ID: 2394004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AV nodal reentrant tachycardia or AV reentrant tachycardia using a concealed bypass tract-related adverse events.
    Brembilla-Perrot B; Bénichou M; Brembilla A; Bozec E; Dorlet S; Sellal JM; Olivier A; Manenti V; Villemin T; Beurrier D; Moulin-Zinsch A; De Chillou C; Girerd N
    Int J Cardiol; 2015 Nov; 199():84-9. PubMed ID: 26188825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ
    Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The retrograde P-wave theory: explaining ST segment depression in supraventricular tachycardia by retrograde AV node conduction.
    Rivera S; De La Paz Ricapito M; Conde D; Verdu MB; Roux JF; Paredes FA
    Pacing Clin Electrophysiol; 2014 Sep; 37(9):1100-5. PubMed ID: 24697871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between atrioventricular node reentrant tachycardia and inducible atrial flutter.
    Kalbfleisch SJ; el-Atassi R; Calkins H; Langberg JJ; Morady F
    J Am Coll Cardiol; 1993 Jul; 22(1):80-4. PubMed ID: 8509568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slow pathway ablation in children with documented reentrant supraventricular tachycardia not inducible during invasive electrophysiologic study.
    Emmel M; Brockmeier K; Sreeram N
    Z Kardiol; 2005 Dec; 94(12):808-12. PubMed ID: 16382381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF; Neuzner J
    Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
    Saksena S; Klein GJ; Kowey PR; Calvo RA; Boccadamo R; Brown JE; Sharma AD; Gadhoke A; Olukotun AY
    Am J Cardiol; 1987 Feb; 59(4):307-12. PubMed ID: 3812280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intravenous sotalol for suppressing inducibility of supraventricular tachycardias at rest and during isometric exercise.
    Huikuri HV; Koistinen MJ; Takkunen JT
    Am J Cardiol; 1992 Feb; 69(5):498-502. PubMed ID: 1736614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective placebo controlled randomized study of caffeine in patients with supraventricular tachycardia undergoing electrophysiologic testing.
    Lemery R; Pecarskie A; Bernick J; Williams K; Wells GA
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):1-6. PubMed ID: 25081280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine Depresses Sinoatrial and Atrioventricular Nodal Function Without Any Change in Atrial Fibrillation Inducibility.
    Sairaku A; Nakano Y; Suenari K; Tokuyama T; Kawazoe H; Matsumura H; Tomomori S; Amioka M; Kihara Y
    J Cardiovasc Pharmacol; 2016 Dec; 68(6):473-478. PubMed ID: 27652911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous adenosine is an antiarrhythmic agent.
    Conti JB; Belardinelli L; Utterback DB; Curtis AB
    Circulation; 1995 Mar; 91(6):1761-7. PubMed ID: 7882485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.